On July 7, the U.S. Food and Drug Administration (FDA) approved Endari (L-glutamine oral powder) for patients age 5 years and older with sickle cell disease to reduce severe complications associated with the disorder. Read more
FDA approves new treatment for sickle cell disease
Most Recent Content
For Nurse Practitioners
Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could
Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...
